Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen

Thumbnail Image
Identifiers
URI: http://hdl.handle.net/11268/2129
DOI: 10.2217/pme.13.60

Publication date

2013

Authors

Fleeman, N.
Payne, K.
Newman, W. G.
Howell, S. J.
Boland, A.

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

Description

UNESCO Subjects

Cáncer
Tratamiento médico

Keywords

Bibliographic reference

Fleeman, N., Payne, K., Newman, W. G., Howell, S. J., Boland, A., Oyee, J., ..., & Dickson, R. (2013). Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen. Personalized Medicine, 10(6), 601-611.

Type of document

journal article

Collections

Área de Ciencias de la Salud